Medications for Leukemia Mastcell

1 result
  • rydapt - rydapt capsule, liquid filled

    (Rydapt)
    Novartis Pharmaceuticals Corporation
    RYDAPT treats adults with newly diagnosed FLT3 mutation-positive AML in combination with chemotherapy (not as single-agent induction), and adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).